These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20103774)

  • 1. Circulating rather than cardiac angiotensin-(1-7) stimulates cardioprotection after myocardial infarction.
    Wang Y; Qian C; Roks AJ; Westermann D; Schumacher SM; Escher F; Schoemaker RG; Reudelhuber TL; van Gilst WH; Schultheiss HP; Tschöpe C; Walther T
    Circ Heart Fail; 2010 Mar; 3(2):286-93. PubMed ID: 20103774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.
    Sevá Pessôa B; Becher PM; Van Veghel R; De Vries R; Tempel D; Sneep S; Van Beusekom H; Van Der Velden VH; Westermann D; Danser AH; Roks AJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25655571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.
    Peiró C; Vallejo S; Gembardt F; Azcutia V; Heringer-Walther S; Rodríguez-Mañas L; Schultheiss HP; Sánchez-Ferrer CF; Walther T
    J Hypertens; 2007 Dec; 25(12):2421-5. PubMed ID: 17984663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro.
    Ocaranza MP; Lavandero S; Jalil JE; Moya J; Pinto M; Novoa U; Apablaza F; Gonzalez L; Hernandez C; Varas M; Lopez R; Godoy I; Verdejo H; Chiong M
    J Hypertens; 2010 May; 28(5):1054-64. PubMed ID: 20411619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
    El-Sabban ME; Hassan KA; Birbari AE; Bitar KM; Bikhazi AB
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):369-78. PubMed ID: 11967826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin II blockade on cardiomyocyte regeneration after myocardial infarction in rats.
    Segersvärd H; Lakkisto P; Forsten H; Immonen K; Kosonen R; Palojoki E; Kankuri E; Harjula A; Laine M; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):92-102. PubMed ID: 23629679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of Epigenetically Modified Adult Cardiac c-Kit+ Cells Retards Remodeling and Improves Cardiac Function in Ischemic Heart Failure Model.
    Zakharova L; Nural-Guvener H; Feehery L; Popovic-Sljukic S; Gaballa MA
    Stem Cells Transl Med; 2015 Sep; 4(9):1086-96. PubMed ID: 26240433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.
    Giani JF; Gironacci MM; Muñoz MC; Turyn D; Dominici FP
    Exp Physiol; 2008 May; 93(5):570-8. PubMed ID: 18448663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM; Burrell LM; Kladis A; Campbell DJ
    J Card Fail; 1997 Mar; 3(1):41-52. PubMed ID: 9110254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
    Tallant EA; Ferrario CM; Gallagher PE
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1560-6. PubMed ID: 15951342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
    Endtmann C; Ebrahimian T; Czech T; Arfa O; Laufs U; Fritz M; Wassmann K; Werner N; Petoumenos V; Nickenig G; Wassmann S
    Hypertension; 2011 Sep; 58(3):394-403. PubMed ID: 21825227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction.
    Ferreira AJ; Jacoby BA; Araújo CA; Macedo FA; Silva GA; Almeida AP; Caliari MV; Santos RA
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1113-9. PubMed ID: 17056670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin 1-7 promotes cardiac angiogenesis following infarction.
    Zhao W; Zhao T; Chen Y; Sun Y
    Curr Vasc Pharmacol; 2015; 13(1):37-42. PubMed ID: 23628010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis.
    Ocaranza MP; Moya J; Barrientos V; Alzamora R; Hevia D; Morales C; Pinto M; Escudero N; García L; Novoa U; Ayala P; Díaz-Araya G; Godoy I; Chiong M; Lavandero S; Jalil JE; Michea L
    J Hypertens; 2014 Apr; 32(4):771-83. PubMed ID: 24463937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.
    Ayach BB; Yoshimitsu M; Dawood F; Sun M; Arab S; Chen M; Higuchi K; Siatskas C; Lee P; Lim H; Zhang J; Cukerman E; Stanford WL; Medin JA; Liu PP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2304-9. PubMed ID: 16467148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrograde coronary vein infusion of cardiac explant-derived c-Kit+ cells improves function in ischemic heart failure.
    Zakharova L; Nural-Guvener H; Feehery L; Popovic S; Nimlos J; Gaballa MA
    J Heart Lung Transplant; 2014 Jun; 33(6):644-53. PubMed ID: 24746638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.